The Kable

The Kable

Share this post

The Kable
The Kable
💊 The climate summit for implementation fails to implement much; A Kable look at the Brazil pharma story
Copy link
Facebook
Email
Notes
More

💊 The climate summit for implementation fails to implement much; A Kable look at the Brazil pharma story

#220 | AstraZeneca donates flu vaccines... not out of choice

Vinod's avatar
Vinod
Nov 21, 2022
∙ Paid

Share this post

The Kable
The Kable
💊 The climate summit for implementation fails to implement much; A Kable look at the Brazil pharma story
Copy link
Facebook
Email
Notes
More
Share

Hello, and welcome back to The Kable. We hope you had a great weekend. We hope it was better than AstraZeneca's, whose price negotiations for flu vaccines dragged on with Swiss authorities for so long the company ended up donating 10,000 doses before they expired.

There was good news, too, for AstraZeneca as it set up a new manufacturing plant in Qassim, Saudi Arabia, in partnership with local drugmaker Saudi Pharmaceutical Industries & Medical Appliances Corporation (Spimaco).

Today's Kable is light, as Mondays often are. But we have some key takeaways from the recently concluded COP27 to mull over. And also the first of our series of market snapshots detailing the market scape in countries across Africa, Latin America and MENA. Today's snapshot takes you surfing across to Brazil, LatAm's biggest market for pharma.

Elsewhere, while the rest of the world looks to move away from Covid, China continues to lean into Zero Covid, now locking down an entire district in Guangzhou and schools across the country returning to online classrooms.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More